SBH
OGN icon

Segall Bryant & Hamill’s Organon & Co OGN Stock Holding History

Segall Bryant & Hamill’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,635
Closed -$208K – 696
2021
Q3 		$208K Sell
6,635
-356
-5% -$11.4K ﹤0.01% 758
2021
Q2 		$211K Buy
+6,991
New +$230K ﹤0.01% 738

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Segall Bryant & Hamill's OGN Position: Q4 2021 in Review

Segall Bryant & Hamill sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 6,635 shares — an estimated $208K sold.

Segall Bryant & Hamill first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $211K in Q2 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Segall Bryant & Hamill reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
  • Segall Bryant & Hamill sold 6,635 Organon & Co shares in Q4 2021, an estimated $208K.
  • Segall Bryant & Hamill first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • Segall Bryant & Hamill's Organon & Co position peaked at $211K in Q2 2021.
  • 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Segall Bryant & Hamill's 13F filing for Q4 2021, filed 14 Feb 2022.